Update News
UPDATE 2-Ranbaxy gets U.S. OK for acne treatment
* Ranbaxy sees U.S. launch of Absorica in Q4
* Cipher, Galephar Pharma to get $9 mln milestone fee
* Cipher to draw royalty on sales from Ranbaxy
* Cipher shares jump 58 pct to a 4-year high on TSX
May 28 (Reuters) - Indian group Ranbaxy Laboratories
has received U.S. approval for acne treatment drug
Absorica and expects a U.S. launch in the fourth quarter of this
year.
Ranbaxy holds
Update Galleries
Update Videos
|
|
